Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

Bibliographic Details
Main Authors:	Lambrechts, Diether, Thienpont, Bernard, Thuillier, Vincent, Sagaert, Xavier, Moisse, Matthieu, Peuteman, Gilian, Pericay, Carles, Folprecht, Gunnar, Zalcberg, John, Zilocchi, Chiara, Margherini, Emmanuelle, Chiron, Marielle, Van Cutsem, Eric
Format:	Online
Language:	English
Published:	Nature Publishing Group 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651136/

id	pubmed-4651136
recordtype	oai_dc
spelling	pubmed-46511362016-09-29 Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting Lambrechts, Diether Thienpont, Bernard Thuillier, Vincent Sagaert, Xavier Moisse, Matthieu Peuteman, Gilian Pericay, Carles Folprecht, Gunnar Zalcberg, John Zilocchi, Chiara Margherini, Emmanuelle Chiron, Marielle Van Cutsem, Eric Translational Therapeutics Nature Publishing Group 2015-09-29 2015-09-10 /pmc/articles/PMC4651136/ /pubmed/26355232 http://dx.doi.org/10.1038/bjc.2015.329 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Lambrechts, Diether Thienpont, Bernard Thuillier, Vincent Sagaert, Xavier Moisse, Matthieu Peuteman, Gilian Pericay, Carles Folprecht, Gunnar Zalcberg, John Zilocchi, Chiara Margherini, Emmanuelle Chiron, Marielle Van Cutsem, Eric
spellingShingle	Lambrechts, Diether Thienpont, Bernard Thuillier, Vincent Sagaert, Xavier Moisse, Matthieu Peuteman, Gilian Pericay, Carles Folprecht, Gunnar Zalcberg, John Zilocchi, Chiara Margherini, Emmanuelle Chiron, Marielle Van Cutsem, Eric Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
author_facet	Lambrechts, Diether Thienpont, Bernard Thuillier, Vincent Sagaert, Xavier Moisse, Matthieu Peuteman, Gilian Pericay, Carles Folprecht, Gunnar Zalcberg, John Zilocchi, Chiara Margherini, Emmanuelle Chiron, Marielle Van Cutsem, Eric
author_sort	Lambrechts, Diether
title	Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
title_short	Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
title_full	Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
title_fullStr	Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
title_full_unstemmed	Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
title_sort	evaluation of efficacy and safety markers in a phase ii study of metastatic colorectal cancer treated with aflibercept in the first-line setting
description
publisher	Nature Publishing Group
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651136/
_version_	1613503352407064576

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

Similar Items